Procalcitonin, C-Reactive Protein and its Correlation with Severity Based on Pediatric Logistic Organ Dysfunction-2 (PELOD-2) Score in Pediatric Sepsis

Runtika Dewi^1, , Dadang Hudaya Somasetia¹ and Nelly Amalia Risan¹

¹Department of Child Health, Hasan Sadikin General Hospital-Universitas Padjadjaran, Bandung, Indonesia

Cite this paper:
Runtika Dewi, Dadang Hudaya Somasetia and Nelly Amalia Risan. Procalcitonin, C-Reactive Protein and its Correlation with Severity Based on Pediatric Logistic Organ Dysfunction-2 (PELOD-2) Score in Pediatric Sepsis. American Journal of Epidemiology and Infectious Disease. 2016; 4(3):64-67. doi: 10.12691/ajeid-4-3-3

Abstract

Background: Periodic procalcitonin (PCT) and C-Reactive Protein (CRP) tests could monitor sepsis response to the therapy, severity, and outcome. Pediatric Logistic Organ Dysfunction Score (PELOD)-2 is a scoring system for predicting organ dysfunction severity progressivity and outcome in critical ill children. The primary endpoint was the correlation of PCT and CRP levels with disease severity based on PELOD-2 score in sepsis children. Methodology and principal findings: A correlational analytical cross-sectional non-clinical trials on periodic measurements of 31 sepsis children was conducted from February to April 2016 in Hasan Sadikin General Hospital Bandung, Indonesia. Eligible subjects were newly diagnosed sepsis (aged ≥1 month to 14 years old). PCT and CRP as well as PELOD-2 scores were assessed in all subjects at T1, T2, and T3. During the study period, 31 sepsis children met the inclusion criteria. In the septic shock group, a significant correlation was found between PCT and PELOD-2 at T3 (p<0,05), between CRP and PELOD-2 score at T3 (p<0,05), and also between PCT and CRP at T2 and T3 (p<0,05). In survivor and non survivor, there was a significant difference in PCT level at T2 and T3 as well as in PELOD-2 score at T1, T2, and T3 but with no significant difference in CRP level for the 3 measurement days. Conclusions: PCT and CRP levels correlate with disease severity based on PELOD-2 score in children with sepsis.

Keywords:
procalcitonin C-Reactive Protein PELOD-2 score pediatric sepsis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Kissoon N, Carapetis J. Pediatric Sepsis in the developing world. J Infect. 2015;71:521-6.
[2]	Bryce J, Pinto CB, Shibuya K, Black RE. WHO estimates of the causes of death in children. Lancet. 2005;365(26):1147-52.
[3]	Singer M, Deutschman CS, Seymour CW, Hari MS, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10.
[4]	Buttery JP. Blood cultures in newborns and children: optimising an everyday test. Arch Dis Child Fetal Neonatal Ed. 2002;87(1):F25-F8.
[5]	Hatzistilianou M. Diagnostic and prognostic role of procalcitonin in infections. The Scientific World J. 2010;10:1941-6.
[6]	Ryu JA, Yang JH, Lee D, Park CM, Suh GY, Jeon K, et al. Clinical usefulness of procalcitonin and C-reactive protein as outcome predictors in critically ill patients with severe sepsis and septic shock. Plos One. 2015;10(9 ):1-12.
[7]	Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-Reactive Protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8(4):R234-42.
[8]	Vincent JL, Moreno R. Clinical review: scoring systems in the critically ill. Crit Care. 2010;14(207):1-9.
[9]	Leteurtre S, Duhamel A, Deken V, Lacroix J, Leclerc F. Daily estimation of the severity organ dysfunctions in critically ill children by using the PELOD-2 score. Crit Care. 2015; 19(324): 1-5.
[10]	Watson RS, Carcillo JA, Zwirble WTL, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the united states. Am J Resp Crit Care Med. 2003;167:695-701.
[11]	Proulx F, Fayon M, Farrell CA, Lacroix J, Gauthier M. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest. 1996;109(4):1033-7.
[12]	Randolph AG, McCulloh RJ. Pediatric sepsis: important considerations for diagnosing and managing severe infections in infant, children, and adolescent. Virulence. 2014;5(1):179-89.
[13]	Szederjesi J, Almasy E, Lazar A, Hutanu A, Badeta I, Georgescu A. An evaluation of serum procalcitonin and c-reactive protein levels as diagnostic and prognostic biomarkers of severe sepsis. J Crit Care Med. 2015;1(4):147-53.
[14]	Aguiar FJB, Junior MF, Sales MM, Neto LMC, Fonseca LAM, Sumita NM, et al. C-reactive protein: clinical applications and proposals for a rational use. 2013;59(1):85-92.
[15]	Li HX, Liu ZM, Zhao SJ, Zhang D, Wang SJ, Wang YS. Measuring both procalcitonin and C-reactive protein for a diagnosis of sepsis in critically ill patients. J Intern Med Res. 2014;42(4):1050-59.
[16]	Hoeboer SH, Groeneveld ABJ. Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients. 2013;8(6):1-7.
[17]	Moodley Y. Procalcitonin, C-reactive protein and prognosis in septic patients. African J Biotech. 2012;11(33):8167-71.
[18]	Azevedo JRAD, Torres OJM, Czeczko NG, Tuon FF, Nassif PAN, Souza GDD. Procalcitonin as a prognostic biomarker of severe sepsis and septic shock. Rev Col Bras Cir. 2012;39(6):456-60.
[19]	Metta D, Soebardja D, Somasetia DH. The use of pediatric logistic organ dysfunction (PELOD) scoring system to determine the prognosis of patients in pediatric intensive care units. Paediatrica Indonesiana. 2006;46(1-2):1-6.